Insulin Prices Double in Pakistan's Khyber-Pakhtunkhwa, Deepening Health Crisis

A sharp surge in the prices of essential medicines has sparked serious concern in Pakistan's Khyber-Pakhtunkhwa province. The cost of a life-saving insulin injection device has more than doubled, placing immense strain on diabetic patients. Prices for other common drugs, including those for thyroid and indigestion, have also seen notable increases, with one thyroid medication rising over 240%. Healthcare professionals warn the hikes may lead to poor treatment adherence and a turn to unsafe alternatives, urging government intervention.

Key Points: Soaring Drug Prices in Pakistan Worsen Healthcare Access

  • Insulin device cost more than doubles
  • Thyroid drug price soars over 240%
  • Patients may skip doses or use unsafe alternatives
  • Pharmacists warn of burden on low-income families
  • Experts urge government subsidies and quality control
2 min read

Pakistan: Soaring drug prices deepen healthcare crisis in Khyber-Pakhtunkhwa

Essential medicine prices, including insulin, surge over 100% in Khyber-Pakhtunkhwa, sparking fears of a healthcare crisis for vulnerable patients.

"This dramatic escalation is likely to place immense financial strain on thousands of diabetic patients - The Express Tribune"

Peshawar, April 12

A sharp surge in the prices of essential medicines, including insulin, has sparked serious concern among patients and healthcare professionals in Khyber-Pakhtunkhwa. The steep increases are expected to disproportionately affect vulnerable populations already grappling with rising living costs, as reported by The Express Tribune.

According to The Express Tribune, the most troubling hike involves insulin, a life-saving medication for diabetes management. The cost of an insulin injection device has more than doubled, rising from Pakistani Rupees (PKR) 2,200 to PKR 4,720. This dramatic escalation is likely to place immense financial strain on thousands of diabetic patients who depend on regular doses to maintain stable blood sugar levels.

Other commonly used medicines have also seen notable increases. A pack used for indigestion and acidity has climbed from PKR 530 to PKR 620, while vitamins and nutritional supplements now cost PKR 510, up from PKR 480. Similarly, the cost of medication for Vitamin B deficiency has increased from PKR 500 to PKR 600. In one of the most drastic revisions, a thyroid drug has surged from PKR 85 to PKR 290, marking an increase of over 240 per cent.

Medicines for typhoid treatment have also become more expensive, with prices rising from PKR 805 to PKR 930. Sources indicate that these revised rates have been approved by regulatory authorities and are already in effect across pharmacies in Peshawar. Additional increases in other critical drugs are also suspected, though details remain unclear. Healthcare professionals warn that such steep price hikes may lead to poor treatment adherence, as patients could skip doses or resort to cheaper, potentially unsafe alternatives, as cited by The Express Tribune.

Pharmacists have echoed similar concerns, highlighting the growing burden on low-income families and elderly patients. Experts are urging the government to reconsider these price adjustments and introduce subsidies or financial relief measures. They also stress the need for strict quality control to prevent the circulation of substandard medicines amid rising demand for affordable options, as reported by The Express Tribune.

- ANI

Share this article:

Reader Comments

P
Priya S
A 240% increase for a thyroid drug? That's not inflation, that's exploitation. 😠 It's the vulnerable who suffer the most in these situations. This news makes me appreciate our own generic medicine schemes like Jan Aushadhi a bit more, though we still have a long way to go. Healthcare should never be this unaffordable.
A
Aman W
The warning about patients resorting to cheaper, unsafe alternatives is the most critical point. When medicine becomes unaffordable, the black market for spurious drugs thrives. This is a serious public health risk that goes beyond just economics. Regulatory authorities need to control prices AND ensure quality.
S
Sarah B
Reading this from a global health perspective. Diabetes is a massive burden in South Asia. Making insulin inaccessible in any country is a step backwards for the entire region's health outcomes. I hope international health organizations are paying attention and can offer support or pressure for policy change.
V
Vikram M
It's a grim situation. While the article is about Khyber-Pakhtunkhwa, it's a stark reminder for all of us in the subcontinent about the importance of strong public health systems and price control on essential drugs. Our hearts go out to the ordinary people suffering. Basic healthcare is a right, not a privilege.
K
Karthik V
With all due respect, the report mentions the hikes are approved by regulators. This begs the question - what is the justification? Is it raw material cost, currency devaluation, or simply profit-seeking by companies? Transparency is needed. Without it, it just looks like the system is failing its citizens.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50